Zeldin RK - Search Results

1

Treatment of chronic autoimmune urticaria with omalizumab.

Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Kaplan AP, et al. Among authors: zeldin rk. J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006. J Allergy Clin Immunol. 2008. PMID: 18774392 Clinical Trial.

2

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.

Massanari M, Nelson H, Casale T, Busse W, Kianifard F, Geba GP, Zeldin RK. Massanari M, et al. Among authors: zeldin rk. J Allergy Clin Immunol. 2010 Feb;125(2):383-9. doi: 10.1016/j.jaci.2009.11.022. J Allergy Clin Immunol. 2010. PMID: 20159249 Clinical Trial.

3

Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthma.

Massanari M, Milgrom H, Pollard S, Maykut RJ, Kianifard F, Fowler-Taylor A, Geba GP, Zeldin RK. Massanari M, et al. Among authors: zeldin rk. Clin Pediatr (Phila). 2009 Oct;48(8):859-65. doi: 10.1177/0009922809339054. Epub 2009 Jun 29. Clin Pediatr (Phila). 2009. PMID: 19564449 Clinical Trial.

4

Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma.

Karpel J, Massanari M, Geba GP, Kianifard F, Inhaber N, Zeldin RK. Karpel J, et al. Among authors: zeldin rk. Ann Allergy Asthma Immunol. 2010 Dec;105(6):465-70. doi: 10.1016/j.anai.2010.09.011. Ann Allergy Asthma Immunol. 2010. PMID: 21130385

5

Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma.

Massanari M, Kianifard F, Zeldin RK, Geba GP. Massanari M, et al. Among authors: zeldin rk. Allergy Asthma Proc. 2009 Sep-Oct;30(5):534-9. doi: 10.2500/aap.2009.30.3245. Epub 2009 May 22. Allergy Asthma Proc. 2009. PMID: 19467177 Clinical Trial.

6

Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber.

Roux M, Devillier P, Yang WH, Montagut A, Abiteboul K, Viatte A, Zeldin RK. Roux M, et al. Among authors: zeldin rk. J Allergy Clin Immunol. 2016 Aug;138(2):451-458.e5. doi: 10.1016/j.jaci.2016.03.039. Epub 2016 May 6. J Allergy Clin Immunol. 2016. PMID: 27289490 Clinical Trial.

7

Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.

Massanari M, Holgate ST, Busse WW, Jimenez P, Kianifard F, Zeldin R. Massanari M, et al. Respir Med. 2010 Feb;104(2):188-96. doi: 10.1016/j.rmed.2009.09.011. Epub 2009 Oct 20. Respir Med. 2010. PMID: 19846286 Free article.

8

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.

Baron-Bodo V, Horiot S, Lautrette A, Chabre H, Drucbert AS, Danzé PM, Sénéchal H, Peltre G, Galvain S, Zeldin RK, Horak F, Moingeon P. Baron-Bodo V, et al. Among authors: zeldin rk. Clin Exp Allergy. 2013 Dec;43(12):1362-73. doi: 10.1111/cea.12187. Clin Exp Allergy. 2013. PMID: 24261946

9

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.

Bergmann KC, Demoly P, Worm M, Fokkens WJ, Carrillo T, Tabar AI, Nguyen H, Montagut A, Zeldin RK. Bergmann KC, et al. Among authors: zeldin rk. J Allergy Clin Immunol. 2014 Jun;133(6):1608-14.e6. doi: 10.1016/j.jaci.2013.11.012. Epub 2013 Dec 31. J Allergy Clin Immunol. 2014. PMID: 24388010 Clinical Trial.

10

Reply: To PMID 24388010.

Bergmann KC, Demoly P, Abiteboul K, Zeldin RK. Bergmann KC, et al. Among authors: zeldin rk. J Allergy Clin Immunol. 2015 Jan;135(1):288-9. doi: 10.1016/j.jaci.2014.09.021. Epub 2014 Oct 28. J Allergy Clin Immunol. 2015. PMID: 25441297 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters